IMM 1.49% 34.0¢ immutep limited

strong support, page-15

  1. 701 Posts.
    Yes oldngrey, CVac has been developed as a platform drug to treat a number of cancers (breast, ovarian, prostate, lung and colon).
    The early steps of extending the research to other indiactions will be confirming the method of action in the ICS data that's about to be released.
    Ovarian is the first cab off the rank due to its unmet need; so is the softer target in terms of approvals.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.